Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Mcot Public Co. Ltd. | OLU | Nov 22, 2024 | 0.16 | -7.95 |
Mcpherson`s Ltd | M5C | Nov 22, 2024 | 0.22 | -3.45 |
Mcphy Energy | M6P | Nov 22, 2024 | 1.15 | -14.18 |
MDU Resources Group, Inc. | MRE | Nov 22, 2024 | 18.40 | +3.37 |
Mears Group PLC | MM7 | Nov 22, 2024 | 4.36 | +0.46 |
Mebuki Financial Group Inc. | 5EE | Nov 22, 2024 | 4.00 | +1.52 |
Medallion Financial Corp. | MD5 | Nov 22, 2024 | 8.80 | +1.15 |
Medapp S.A. | WQ1 | Nov 22, 2024 | 0.03 | +2.52 |
Medaro Mining | 1ZY0 | Nov 22, 2024 | 0.09 | 0.00 |
MEDBRIGHT AI INVTS INC. | Y30 | Nov 22, 2024 | 0.01 | 0.00 |
MedCap | 61MA | Nov 22, 2024 | 46.45 | +4.62 |
Medesis Pharma S.A. | 76D | Nov 22, 2024 | 0.35 | +5.74 |
Medexus Pharmaceuticals Inc | P731 | Nov 22, 2024 | 1.38 | 0.00 |
Media and Games Invest SE | M8G | Nov 22, 2024 | 3.98 | +6.84 |
Mediaco Holding Inc. - Class A | 3WX | Nov 22, 2024 | 1.19 | +5.31 |
MEDIAN POLSKA S.A. ZY-,10 | GY3 | Nov 22, 2024 | 0.15 | 0.00 |
Median Technologies | 4ZG | Nov 22, 2024 | 3.38 | -8.77 |
Medibank Private Limited | MPV | Nov 22, 2024 | 2.26 | +0.89 |
Medical Facilities Corp | 31F | Nov 22, 2024 | 10.80 | +3.85 |
Medical Properties Trust Inc | M3P | Nov 22, 2024 | 4.06 | +2.76 |
Mediclin AG | MED | Nov 22, 2024 | 2.46 | -1.60 |
Medicover B | 5M0B | Nov 22, 2024 | 14.78 | -0.14 |
Medicure Inc | NGQ1 | Nov 22, 2024 | 0.60 | +2.56 |
MEDICUS PHARMA LTD. | N46 | Nov 22, 2024 | 0.57 | 0.00 |
MEDICUS PHARMA LTD. | N460 | Nov 22, 2024 | 2.73 | 0.00 |
MEDIFAST INC | MDF | Nov 22, 2024 | 17.02 | +1.49 |
Medigene AG | MDG1 | Nov 22, 2024 | 1.53 | -0.52 |
Medimi | 79T | Nov 22, 2024 | 0.00 | 0.00 |
Medincell S.A. | MEB | Nov 22, 2024 | 16.90 | 0.00 |
MEDIOBANCA S.P.A.UNSP.ADR | ME90 | Nov 22, 2024 | 13.70 | -0.72 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.